{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:59:50Z","timestamp":1790222390407,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The benefit of Inhaled nitric oxide (iNO) therapy in the setting of COVID-19-related ARDS is obscure. We performed a multicenter retrospective study to evaluate the impact of iNO on patients with COVID-19 who require respiratory support.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective multicenter study included COVID-19 patients enrolled in the SCCM VIRUS COVID-19 registry who were admitted to different Mayo Clinic sites between March 2020 and June 2022 and required high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), or invasive mechanical ventilation (IMV). Patients were included in the \u2018spontaneously breathing\u2019 group if they remained non-intubated or were initiated on an HFNC (\u00b1\u2009NIV) before intubation. Patients who got intubated without prior use of an HFNC (\u00b1\u2009NIV) were included in the \u2018intubated group.\u2019 They were further divided into categories based on their iNO usage. Propensity score matching (PSM) and inverse propensity of treatment weighting (IPTW) were performed to examine outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 2767 patients included in our analysis, 1879 belonged to spontaneously breathing (153 received iNO), and 888 belonged to the intubated group (193 received iNO). There was a consistent improvement in FiO2 requirement, P\/F ratio, and respiratory rate within 48\u00a0h of iNO use among both spontaneously breathing and intubated groups. However, there was no significant difference in intubation risk with iNO use among spontaneously breathing patients (PSM OR 1.08, CI 0.71\u20131.65; IPTW OR 1.10, CI 0.90\u20131.33). In a time-to-event analysis using Cox proportional hazard model, spontaneously breathing patients initiated on iNO had a lower hazard ratio of in-hospital mortality (PSM HR 0.49, CI 0.32\u20130.75, IPTW HR 0.40, 95% CI 0.26\u20130.62) but intubated patients\u00a0did not (PSM HR: 0.90; CI 0.66\u20131.24, IPTW HR 0.98, 95% CI 0.73\u20131.31). iNO use was associated with longer in-hospital stays, ICU stays, ventilation duration, and a higher incidence of creatinine rise.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This retrospective propensity-score matched study showed that spontaneously breathing COVID-19 patients on HFNC\/ NIV support had a decreased in-hospital mortality risk with iNO use in a time-to-event analysis. Both intubated and spontaneously breathing patients had improvement in oxygenation parameters with iNO therapy but were associated with longer in-hospital stays, ICU stays, ventilation duration, and higher incidence of creatinine rise.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-024-05093-w","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T16:01:59Z","timestamp":1729872119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study"],"prefix":"10.1186","volume":"28","author":[{"given":"Shahin","family":"Isha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanth","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby J.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Jonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekhya","family":"Raavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subekshya","family":"Khadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Vasudhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sinclair De Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Balavenkataraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Caples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Anjum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail T.","family":"LaNou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Cartin-Ceba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Diaz","family":"Milian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla P.","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna B.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Kiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quintin J.","family":"Quinones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Moreno Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devang K.","family":"Sanghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"issue":"3 Pt 1","key":"5093_CR1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","volume":"149","author":"GR Bernard","year":"1994","unstructured":"Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818\u201324.","journal-title":"Am J Respir Crit Care Med."},{"issue":"1","key":"5093_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12890-019-0803-0","volume":"19","author":"T Kamo","year":"2019","unstructured":"Kamo T, Tasaka S, Suzuki T, Asakura T, Suzuki S, Yagi K, et al. Prognostic values of the Berlin definition criteria, blood lactate level, and fibroproliferative changes on high-resolution computed tomography in ARDS patients. BMC Pulm Med. 2019;19(1):37.","journal-title":"BMC Pulm Med"},{"key":"5093_CR3","doi-asserted-by":"crossref","unstructured":"ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333.","DOI":"10.1001\/jama.2012.5669"},{"issue":"6","key":"5093_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJM199302113280605","volume":"328","author":"R Rossaint","year":"1993","unstructured":"Rossaint R, Falke KJ, L\u00f3pez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328(6):399\u2013405.","journal-title":"N Engl J Med"},{"issue":"3","key":"5093_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/cc7734","volume":"13","author":"BC Creagh-Brown","year":"2009","unstructured":"Creagh-Brown BC, Griffiths MJD, Evans TW. Bench-to-bedside review: Inhaled nitric oxide therapy in adults. Crit Care Lond Engl. 2009;13(3):221.","journal-title":"Crit Care Lond Engl"},{"issue":"15","key":"5093_CR6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.97.15.1481","volume":"97","author":"A Gries","year":"1998","unstructured":"Gries A, Bode C, Peter K, Herr A, B\u00f6hrer H, Motsch J, et al. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation. 1998;97(15):1481\u20137.","journal-title":"Circulation"},{"issue":"2","key":"5093_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-0037-1613804","volume":"83","author":"A Gries","year":"2000","unstructured":"Gries A, Herr A, Motsch J, Holzmann A, Weimann J, Taut F, et al. Randomized, placebo-controlled, blinded and cross-matched study on the antiplatelet effect of inhaled nitric oxide in healthy volunteers. Thromb Haemost. 2000;83(2):309\u201315.","journal-title":"Thromb Haemost"},{"key":"5093_CR8","first-page":"74","volume":"4","author":"JL Hunt","year":"2016","unstructured":"Hunt JL, Bronicki RA, Anas N. Role of inhaled nitric oxide in the management of severe acute respiratory distress syndrome. Front Pediatr. 2016;4:74.","journal-title":"Front Pediatr"},{"issue":"1","key":"5093_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/anae.13628","volume":"72","author":"O Karam","year":"2017","unstructured":"Karam O, Gebistorf F, Wetterslev J, Afshari A. The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: a cochrane systematic review with trial sequential analysis. Anaesthesia. 2017;72(1):106\u201317.","journal-title":"Anaesthesia"},{"issue":"7597","key":"5093_CR10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.39139.716794.55","volume":"334","author":"NKJ Adhikari","year":"2007","unstructured":"Adhikari NKJ, Burns KEA, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007;334(7597):779.","journal-title":"BMJ"},{"issue":"1","key":"5093_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13613-023-01150-9","volume":"13","author":"A MekontsoDessap","year":"2023","unstructured":"MekontsoDessap A, Papazian L, Schaller M, Nseir S, Megarbane B, Haudebourg L, et al. Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes. Ann Intensive Care. 2023;13(1):57.","journal-title":"Ann Intensive Care"},{"key":"5093_CR12","doi-asserted-by":"crossref","unstructured":"Gebistorf F, Karam O, Wetterslev J, Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016;2016(6):CD002787.","DOI":"10.1002\/14651858.CD002787.pub3"},{"issue":"7","key":"5093_CR13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"5093_CR14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202006-2405OC","volume":"203","author":"ZJ Lim","year":"2021","unstructured":"Lim ZJ, Subramaniam A, Ponnapa Reddy M, Blecher G, Kadam U, Afroz A, et al. Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A Meta-analysis. Am J Respir Crit Care Med. 2021;203(1):54\u201366.","journal-title":"Am J Respir Crit Care Med."},{"issue":"3","key":"5093_CR15","volume":"16","author":"E Oliveira","year":"2021","unstructured":"Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, et al. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS ONE. 2021;16(3): e0249038.","journal-title":"PLoS ONE"},{"issue":"11","key":"5093_CR16","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.202003-0736LE","volume":"201","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020;201(11):1430\u20134.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5093_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"5093_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41479-021-00092-9","volume":"13","author":"A Aslan","year":"2021","unstructured":"Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia Nathan Qld. 2021;13(1):14.","journal-title":"Pneumonia Nathan Qld"},{"issue":"5","key":"5093_CR19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani W, M\u00f8ller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854\u201387.","journal-title":"Intensive Care Med"},{"issue":"5","key":"5093_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S2213-2600(20)30127-2","volume":"8","author":"MA Matthay","year":"2020","unstructured":"Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med. 2020;8(5):433\u20134.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"5093_CR21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ehf2.13023","volume":"8","author":"WX Feng","year":"2021","unstructured":"Feng WX, Yang Y, Wen J, Liu YX, Liu L, Feng C. Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension. ESC Heart Fail. 2021;8(1):714\u20138.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"5093_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13613-020-00681-9","volume":"10","author":"J Kobayashi","year":"2020","unstructured":"Kobayashi J, Murata I. Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome. Ann Intensive Care. 2020;10(1):61.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"5093_CR23","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/JVI.79.3.1966-1969.2005","volume":"79","author":"S \u00c5kerstr\u00f6m","year":"2005","unstructured":"\u00c5kerstr\u00f6m S, Mousavi-Jazi M, Klingstr\u00f6m J, Leijon M, Lundkvist \u00c5, Mirazimi A. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005;79(3):1966\u20139.","journal-title":"J Virol"},{"issue":"13","key":"5093_CR24","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.291.13.1603","volume":"291","author":"RW Taylor","year":"2004","unstructured":"Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004;291(13):1603\u20139.","journal-title":"JAMA"},{"key":"5093_CR25","doi-asserted-by":"crossref","unstructured":"Abman SH, Fox NR, Malik MI, Kelkar SS, Corman SL, Rege S, et al. Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome. Drugs Context. 2022;11:2022\u20131\u20134.","DOI":"10.7573\/dic.2022-1-4"},{"key":"5093_CR26","doi-asserted-by":"crossref","first-page":"117954842110470","DOI":"10.1177\/11795484211047065","volume":"15","author":"A Chandel","year":"2021","unstructured":"Chandel A, Patolia S, Ahmad K, Aryal S, Brown AW, Sahjwani D, et al. Inhaled nitric oxide via high-flow nasal cannula in patients with acute respiratory failure related to COVID-19. Clin Med Insights Circ Respir Pulm Med. 2021;15:11795484211047064.","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"issue":"116","key":"5093_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2021.08.003","volume":"1","author":"B SafaeeFakhr","year":"2021","unstructured":"SafaeeFakhr B, Di Fenza R, Gianni S, Wiegand SB, Miyazaki Y, Araujo Morais CC, et al. Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia. Nitric Oxide Biol Chem. 2021;1(116):7\u201313.","journal-title":"Nitric Oxide Biol Chem"},{"issue":"1","key":"5093_CR28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s13054-020-03222-9","volume":"24","author":"G Tavazzi","year":"2020","unstructured":"Tavazzi G, Pozzi M, Mongodi S, Dammassa V, Romito G, Mojoli F. Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia. Crit Care Lond Engl. 2020;24(1):508.","journal-title":"Crit Care Lond Engl"},{"issue":"6","key":"5093_CR29","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000471","volume":"3","author":"DR Ziehr","year":"2021","unstructured":"Ziehr DR, Alladina J, Wolf ME, Brait KL, Malhotra A, La Vita C, et al. Respiratory physiology of prone positioning with and without inhaled nitric oxide across the coronavirus disease 2019 acute respiratory distress syndrome severity spectrum. Crit Care Explor. 2021;3(6): e0471.","journal-title":"Crit Care Explor"},{"issue":"12","key":"5093_CR30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1164\/rccm.202304-0637OC","volume":"208","author":"R Di Fenza","year":"2023","unstructured":"Di Fenza R, Shetty NS, Gianni S, Parcha V, Giammatteo V, SafaeeFakhr B, et al. High-dose inhaled nitric oxide in acute hypoxemic respiratory failure due to COVID-19: a multicenter phase II Trial. Am J Respir Crit Care Med. 2023;208(12):1293\u2013304.","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"5093_CR31","doi-asserted-by":"crossref","first-page":"12803","DOI":"10.3390\/ijerph191912803","volume":"19","author":"JS Alqahtani","year":"2022","unstructured":"Alqahtani JS, Aldhahir AM, Al Ghamdi SS, AlBahrani S, AlDraiwiesh IA, Alqarni AA, et al. Inhaled nitric oxide for clinical management of COVID-19: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19):12803.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"5093_CR32","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1097\/CCM.0000000000004572","volume":"48","author":"AJ Walkey","year":"2020","unstructured":"Walkey AJ, Sheldrick RC, Kashyap R, Kumar VK, Boman K, Bolesta S, et al. Guiding principles for the conduct of observational critical care research for coronavirus disease 2019 pandemics and beyond: the society of critical care medicine discovery viral infection and respiratory illness universal study registry. Crit Care Med. 2020;48(11):e1038\u201344.","journal-title":"Crit Care Med"},{"issue":"11","key":"5093_CR33","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1097\/CCM.0000000000004572","volume":"48","author":"AJ Walkey","year":"2020","unstructured":"Walkey AJ, Sheldrick RC, Kashyap R, Kumar VK, Boman K, Bolesta S, et al. Guiding principles for the conduct of observational critical care research for coronavirus disease 2019 pandemics and beyond: the society of critical care medicine discovery viral infection and respiratory illness universal study registry. Crit Care Med. 2020;48(11):e1038\u201344.","journal-title":"Crit Care Med"},{"issue":"3","key":"5093_CR34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/CCM.0000000000004879","volume":"49","author":"JP Domecq","year":"2021","unstructured":"Domecq JP, Lal A, Sheldrick CR, Kumar VK, Boman K, Bolesta S, et al. Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry. Crit Care Med. 2021;49(3):437\u201348.","journal-title":"Crit Care Med"},{"key":"5093_CR35","doi-asserted-by":"crossref","unstructured":"Yarrarapu SNS, Bansal P, Abia-Trujillo D, Cusick A, Melody M, Moktan V, et al. V.I.T.A.M. in COVID 19: A Systematic Approach to a Global Pandemic. Clin Med Insights Circ Respir Pulm Med. 2021;15:11795484211047432.","DOI":"10.1177\/11795484211047432"},{"key":"5093_CR36","doi-asserted-by":"crossref","unstructured":"Section 2: AKI definition. Kidney Int Suppl. 2012;2(1):19\u201336.","DOI":"10.1038\/kisup.2011.32"},{"key":"5093_CR37","doi-asserted-by":"crossref","unstructured":"Ho DE, Imai K, King G, Stuart EA. MatchIt\u202f: Nonparametric Preprocessing for Parametric Causal Inference. J Stat Softw [Internet]. 2011 [cited 2024 May 4];42(8). http:\/\/www.jstatsoft.org\/v42\/i08\/","DOI":"10.18637\/jss.v042.i08"},{"issue":"9","key":"5093_CR38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40266-021-00876-0","volume":"38","author":"LJ Seppala","year":"2021","unstructured":"Seppala LJ, van de Loo B, Schut M, van Schoor NM, Stricker BH, Kenny RA, et al. A propensity score matched approach to assess the associations of commonly prescribed medications with fall risk in a large harmonized cohort of older ambulatory persons. Drugs Aging. 2021;38(9):797\u2013805.","journal-title":"Drugs Aging"},{"issue":"7","key":"5093_CR39","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7):1242\u201358.","journal-title":"Stat Med"},{"issue":"1","key":"5093_CR40","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.bja.2020.10.011","volume":"126","author":"A Longobardo","year":"2021","unstructured":"Longobardo A, Montanari C, Shulman R, Benhalim S, Singer M, Arulkumaran N. Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome. Br J Anaesth. 2021;126(1):e44\u20136.","journal-title":"Br J Anaesth"},{"issue":"8","key":"5093_CR41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00134-021-06459-2","volume":"47","author":"DL Grieco","year":"2021","unstructured":"Grieco DL, Maggiore SM, Roca O, Spinelli E, Patel BK, Thille AW, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851\u201366.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5093_CR42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.201605-1081CP","volume":"195","author":"L Brochard","year":"2017","unstructured":"Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438\u201342.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"5093_CR43","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000863","volume":"5","author":"JC Grotberg","year":"2023","unstructured":"Grotberg JC, Kraft BD. Timing of intubation in COVID-19: when it is too early and when it is too late. Crit Care Explor. 2023;5(2): e0863.","journal-title":"Crit Care Explor"},{"issue":"1","key":"5093_CR44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13054-020-03063-6","volume":"24","author":"E Villarreal-Fernandez","year":"2020","unstructured":"Villarreal-Fernandez E, Patel R, Golamari R, Khalid M, DeWaters A, Haouzi P. A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure. Crit Care Lond Engl. 2020;24(1):337.","journal-title":"Crit Care Lond Engl"},{"key":"5093_CR45","doi-asserted-by":"crossref","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. 2020; https:\/\/apps.who.int\/iris\/handle\/10665\/331446","DOI":"10.15557\/PiMR.2020.0003"},{"issue":"4","key":"5093_CR46","volume":"8","author":"JCH Cheung","year":"2020","unstructured":"Cheung JCH, Ho LT, Cheng JV, Cham EYK, Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. 2020;8(4): e19.","journal-title":"Lancet Respir Med"},{"issue":"22","key":"5093_CR47","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.2020.6825","volume":"323","author":"JJ Marini","year":"2020","unstructured":"Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329\u201330.","journal-title":"JAMA"},{"issue":"2","key":"5093_CR48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/emp2.12063","volume":"1","author":"CA Brown","year":"2020","unstructured":"Brown CA, Mosier JM, Carlson JN, Gibbs MA. Pragmatic recommendations for intubating critically ill patients with suspected COVID-19. J Am Coll Emerg Physicians Open. 2020;1(2):80\u20134.","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"7","key":"5093_CR49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-2600(21)00175-2","volume":"9","author":"AB Docherty","year":"2021","unstructured":"Docherty AB, Mulholland RH, Lone NI, Cheyne CP, De Angelis D, Diaz-Ordaz K, et al. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021;9(7):773\u201385.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"5093_CR50","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000452","volume":"3","author":"AJ Parish","year":"2021","unstructured":"Parish AJ, West JR, Caputo ND, Janus TM, Yuan D, Zhang J, et al. Early intubation and increased coronavirus disease 2019 mortality: A propensity score-matched retrospective cohort study. Crit Care Explor. 2021;3(6): e0452.","journal-title":"Crit Care Explor"},{"issue":"6","key":"5093_CR51","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.2022.0028","volume":"327","author":"GD Perkins","year":"2022","unstructured":"Perkins GD, Ji C, Connolly BA, Couper K, Lall R, Baillie JK, et al. Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial. JAMA. 2022;327(6):546\u201358.","journal-title":"JAMA"},{"issue":"1","key":"5093_CR52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13054-022-03966-6","volume":"26","author":"L Camous","year":"2022","unstructured":"Camous L, Pommier JD, Martino F, Tressieres B, Demoule A, Valette M. Very late intubation in COVID-19 patients: a forgotten prognosis factor? Crit Care Lond Engl. 2022;26(1):89.","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"5093_CR53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262315","volume":"17","author":"C Karagiannidis","year":"2022","unstructured":"Karagiannidis C, Hentschker C, Westhoff M, Weber-Carstens S, Janssens U, Kluge S, et al. Observational study of changes in utilization and outcomes in mechanical ventilation in COVID-19. PLoS ONE. 2022;17(1): e0262315.","journal-title":"PLoS ONE"},{"issue":"1","key":"5093_CR54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13054-021-03882-1","volume":"26","author":"J Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez J, Ben\u00edtez ID, de Gonzalo-Calvo D, Torres G, de Batlle J, G\u00f3mez S, et al. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study. Crit Care Lond Engl. 2022;26(1):18.","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"5093_CR55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13054-022-04082-1","volume":"26","author":"K Polok","year":"2022","unstructured":"Polok K, Fronczek J, Artigas A, Flaatten H, Guidet B, De Lange DW, et al. Noninvasive ventilation in COVID-19 patients aged \u2265 70 years-a prospective multicentre cohort study. Crit Care Lond Engl. 2022;26(1):224.","journal-title":"Crit Care Lond Engl"},{"issue":"10","key":"5093_CR56","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000254","volume":"2","author":"JB Hyman","year":"2020","unstructured":"Hyman JB, Leibner ES, Tandon P, Egorova NN, Bassily-Marcus A, Kohli-Seth R, et al. Timing of intubation and in-hospital mortality in patients with coronavirus disease 2019. Crit Care Explor. 2020;2(10): e0254.","journal-title":"Crit Care Explor"},{"key":"5093_CR57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jcrc.2021.06.008","volume":"65","author":"M Vera","year":"2021","unstructured":"Vera M, Kattan E, Born P, Rivas E, Amthauer M, Nesvadba A, et al. Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection. J Crit Care. 2021;65:164\u20139.","journal-title":"J Crit Care"},{"issue":"2","key":"5093_CR58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1513\/AnnalsATS.202102-161OC","volume":"19","author":"W Shu","year":"2022","unstructured":"Shu W, Guo S, Yang F, Liu B, Zhang Z, Liu X, et al. Association between ARDS etiology and risk of noninvasive ventilation failure. Ann Am Thorac Soc. 2022;19(2):255\u201363.","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"5093_CR59","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","volume":"199","author":"O Roca","year":"2019","unstructured":"Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hern\u00e1ndez G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"5093_CR60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcrc.2016.05.022","volume":"35","author":"O Roca","year":"2016","unstructured":"Roca O, Messika J, Caralt B, Garc\u00eda-de-Acilu M, Sztrymf B, Ricard JD, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care. 2016;35:200\u20135.","journal-title":"J Crit Care"},{"issue":"2","key":"5093_CR61","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/CCM.0b013e3182a27909","volume":"42","author":"NKJ Adhikari","year":"2014","unstructured":"Adhikari NKJ, Dellinger RP, Lundin S, Payen D, Vallet B, Gerlach H, et al. Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis*. Crit Care Med. 2014;42(2):404\u201312.","journal-title":"Crit Care Med"},{"key":"5093_CR62","first-page":"175346662093351","volume":"14","author":"R Parikh","year":"2020","unstructured":"Parikh R, Wilson C, Weinberg J, Gavin D, Murphy J, Reardon CC. Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients. Ther Adv Respir Dis. 2020;14:175346662093351.","journal-title":"Ther Adv Respir Dis"},{"key":"5093_CR63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcrc.2020.08.007","volume":"60","author":"M Ferrari","year":"2020","unstructured":"Ferrari M, Santini A, Protti A, Andreis DT, Iapichino G, Castellani G, et al. Inhaled nitric oxide in mechanically ventilated patients with COVID-19. J Crit Care. 2020;60:159\u201360.","journal-title":"J Crit Care"},{"issue":"1","key":"5093_CR64","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13054-022-04158-y","volume":"26","author":"K Al Sulaiman","year":"2022","unstructured":"Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, et al. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Crit Care. 2022;26(1):304.","journal-title":"Crit Care"},{"issue":"1","key":"5093_CR65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/0886022X.2021.1873805","volume":"43","author":"J Wang","year":"2021","unstructured":"Wang J, Cong X, Miao M, Yang Y, Zhang J. Inhaled nitric oxide and acute kidney injury risk: a meta-analysis of randomized controlled trials. Ren Fail. 2021;43(1):281\u201390.","journal-title":"Ren Fail"},{"key":"5093_CR66","doi-asserted-by":"crossref","unstructured":"Zapol WM, Hurford WE. Inhaled Nitric Oxide in Adult Respiratory Distress Syndrome and Other Lung Diseases. In: Advances in Pharmacology [Internet]. Elsevier; 1994 [cited 2024 Jul 6]. p. 513\u201330. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358908606390","DOI":"10.1016\/S1054-3589(08)60639-0"},{"issue":"7","key":"5093_CR67","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.2108121","volume":"167","author":"H Gerlach","year":"2003","unstructured":"Gerlach H, Keh D, Semmerow A, Busch T, Lewandowski K, Pappert DM, et al. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med. 2003;167(7):1008\u201315.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-05093-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:07:41Z","timestamp":1736302061000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-05093-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5093"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-05093-w","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed under the exemption criteria from the Mayo Clinic Institutional Review Board. Access to the multicenter Mayo Clinic data was granted through \u201cViral Infection and Respiratory Illness Universal Study [VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)\u201d under IRB ID 20\u2013002610. The need for informed consent was waived by the IRB due to its retrospective design, data anonymity, and non-interventional nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Rahul Kashyap: Grant and contracts\u2014Gordan and Betty Moore Foundation, Jenssen and Jenssen LLC; all payments made to the institution. No conflict of interest related to this manuscript. Rest other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}